Problem Solving In Cancer Immunotherapy

· a multidisciplinary review including the latest developments in cancer immunotherapy from over 70 experts and leaders · hands-on, practical guide to immunotherapy for hospital and community teams, GPs and allied care professionals, including 23 case studies · a valuable learning tool for doctors, nurses, graduate medical trainees, care managers and anyone involved in cancer care produced in partnership with the Association of Cancer Physicians (ACP) Editors and authors have drawn on their expertise and growing experience of immunotherapy to produce this practical guide to cancer immunotherapy. It provides a compendium of best practice, including 23 case studies to act as models for professionals making decisions, either for individual patients or as the basis for using immunotherapy across an organisation, planning area, region or country. As well as introducing key concepts, expert practitioners provide a guide to future treatments using novel technologies, discuss key problems and suggest solutions, and consider the costs of immunotherapy treatments. This guide is designed as a handbook for practising clinicians and professionals. It is also an excellent training tool that will help new teams and clinical staff to align thinking, develop procedures, and adopt best practice.

Winner of the BMA Oncology Book of the Year Award. The authors provide a compendium of best practice, including 25 case studies to act as models for professionals to make decisions, either for individual patients or as the basis for policy across an organisation, planning area, region or country. This guide is designed as a handbook for practising clinicians and professionals. It is also an excellent training tool, which will help new teams and clinical staff to align thinking, develop procedures, and adopt best practice.

This practical manual in the care of older cancer patients won best oncology book in the BMA Medical Book Awards 2016, and is an essential tool created as a joint project of the Association of Cancer Physicians (ACP) and the British Geriatric Society (BGS). Written by 134 contributors who are all experts in their fields, it offers an overview of the latest developments, with 32 real life case studies. It is a valuable learning and reference resource for doctors, nurses, trainees and other professionals managing cancer in older patients. This evidence-based guidebook will assist the physician in managing the older cancer patient when implementing the appropriate treatment strategy, taking account of comorbidities, frailty, and patient choice. Each clinical case includes a concise discussion on patient presentation and of scenarios underpinning issues experienced by older patients followed by a clear appraisal of how the latest clinical research impacts on patient management. This large cohort of patients requires both innovative care and individual attention, and this carefully crafted book shares the experience of an expert multidisciplinary team in the interest of patient-centred care. It is essential reading for specialists in oncology, specialists in geriatric care, general physicians, doctors in training, oncology nurses, healthcare managers and administrators.

This original book in the Problem Solving in Oncology Series, this volume brings together the thinking in both investigation and management of the cancer patient. It presents a comprehensive caseload as seen by the oncologist with common yet challenging real-life patient scenarios. Each case begins with a few practical questions to stimulate the reader. This is followed by clinical presentation and the reader is led through the logical work-up of a case to reach a diagnosis. An algorithm accompanies most cases to provide a rapid pictorial overview of the clinical steps involved. Essential references are provided. Each of the major areas of cancer is covered, along with pain, management of chemotherapy, and psychological issues. This book is an essential companion for the oncologist, for the specialist in other areas seeking to improve his understanding of cancer, and for the interested GP.

The treatment of cancer in young women and men is increasingly turning from focusing purely on survival to a recognition of the long-term effects of treatment on subsequent quality of life. In this regard, fertility is a very high priority for patients. This is the first book to explain the latest techniques in fertility preservation. Chapters cover fertility preservation in both women and men, management of cancer in pregnancy, egg donation and surrogacy, hormone replacement options, counselling and ethical issues. A multidisciplinary team of over 60 specialists were involved in this work, with contributions from leading obstetricians, medical oncologists, gynaecological oncologists, urologists and fertility specialists. The book is formally supported by the Association of Cancer Physicians (ACP). This highly patient-centred, readable text will be of value to a wide range of clinicians and physicians, and doctors in training, in their daily work.

Winner of the BMA Oncology Book of the Year Award. This practical learning and reference handbook provides an overview of the latest progress in the developing field of precision oncology, plus a ground breaking collection of case studies ("Problems") showing precision oncology in practice. The book includes a clear, readable summary of developments, alongside real-life case studies, providing a valuable update for all involved in the oncology community. The editors lead research and clinical teams at four UK centres of excellence in the field.

Immunotherapy is a form of cancer therapy that harnesses the body's immune system to destroy cancer cells. In recent years, immunotherapies have been developed for several cancers, including advanced melanoma, lung cancer, and kidney cancer. In some patients with metastatic cancers who have not responded well to other treatments, immunotherapy treatment has resulted in complete and durable responses. Given these promising findings, it is hoped that continued immunotherapy research and development will produce better cancer treatments that improve patient outcomes. With this promise, however, there is also recognition that the clinical and biological landscape for immunotherapies is novel and not yet well understood. For example, adverse events with immunotherapy treatment are quite different from those experienced with other types of cancer therapy. Similarly, immunotherapy dosing, therapeutic responses, and response time lines are also markedly different from other cancer therapies. To examine these challenges and explore strategies to overcome them, the National Academies of Sciences, Engineering, and Medicine held a workshop in February and March of 2016. This report summarizes the presentations and discussions from the workshop.